How Urgent Care Centers Are Valued
Urgent care is one of the most active healthcare M&A categories of the last decade. PE-backed roll-ups (FastMed, GoHealth, MedExpress, American Family Care, NextCare, Concentra), hospital systems building outpatient footprints, and increasingly retail clinics (CVS MinuteClinic, Walmart Health, Amazon One Medical) are all acquirers — and each pays differently for the same EBITDA.
What separates a 4x clinic from a 12x platform isn't scale alone. It's a combination of patient volume per day, payer mix, the sustainability of provider staffing, and whether the locations sit on the right corner.
Single-Clinic Urgent Care: 4-7x EBITDA
A standalone urgent care doing $1.5-3M in revenue with $250-600K EBITDA typically trades at 4-7x EBITDA. The bottom of the range reflects clinics with: patient volume under 30/day, heavy Medicaid payer mix, owner-physician dependency, and short-term lease risk. The top reflects 60+ patients/day, balanced commercial payer mix (50%+ commercial), no single-physician dependency, and 7+ years on the lease (or owned real estate).
Real estate matters more for urgent care than for most healthcare verticals. Locations are largely fungible operationally — the value of a specific clinic is heavily tied to its visibility, traffic count, and demographics. If you own the building, expect a separate real estate appraisal that often adds 30-50% to total deal value.
Multi-Clinic Regional Platform: 8-12x EBITDA
Once you hit 5-15 clinics under a single brand with shared back-office (centralized billing, scheduling, EMR, supply chain), you become attractive to regional PE platforms looking for tuck-ins or to a larger national platform looking for geographic expansion. Multiples typically run 8-12x EBITDA, and the spread inside that range is driven by:
- EBITDA margin trend: 18%+ margins with stable trend get top-of-range; declining margins (typical of mid-2024-2026 staffing pressure) get discounted.
- Provider model: clinics staffed primarily with physician-owners or ER-trained physicians command premium; PA/NP-only models command discount.
- Occupational health contracts: B2B contracts with local employers (drug screens, work physicals, injury care) add recurring revenue and hit valuation hard at the multiple level because they're sticky and prepaid.
PE-Backed National Platforms: 10-13x EBITDA
At 30+ clinics with national or super-regional footprint, you're in the conversation with strategic and large-cap PE buyers. Comps include FastMed, GoHealth, AFC (American Family Care), Concentra (now owned by Select Medical at $3.6B+), and Patient First. Multiples in recent transactions: 10-13x EBITDA, occasionally higher when there's a clear buyer-side scarcity (e.g., last platform of size in a hot region).
Key Value Drivers
Patient volume per day is the most-asked-about metric. Buyers benchmark against industry norm: 35-50 patients/day is healthy; 60+ is premium; under 25 is a red flag suggesting either under-utilization or saturated competition. Volume trend matters as much as absolute level.
Payer mix directly impacts profitability. Commercial insurance (BCBS, Aetna, Cigna, UHC) reimburses 2-3x what Medicaid pays for the same code. Cash-pay urgent care (often near tourist areas or in markets with high uninsured populations) commands premium because collections are clean and immediate.
Location quality: visible from the road, anchor in a shopping center, on a high-traffic corner with parking. Clinics in second-row strip malls trade at meaningful discounts even with similar volumes.
Extended hours: 7-day, evening-open clinics command premium. The whole urgent care thesis vs. primary care is convenience — clinics that don't deliver convenience get discounted.
What Reduces Urgent Care Valuations
Provider staffing instability is the #1 issue in 2026. Locum tenens dependency, frequent provider turnover, or open shifts covered by traveling staff materially reduces multiples — buyers see staffing as an existential risk and underwrite conservatively.
Reimbursement pressure: clinics with rates locked at below-market commercial reimbursement get discounted because buyers assume the contracts will renew at lower rates.
Retail clinic competition: CVS MinuteClinic, Walmart Health, and Amazon One Medical opening within 3 miles of your clinic typically reduces valuation 10-20% due to projected volume erosion — even before the volume actually erodes.
Malpractice claims history: any claims in the trailing 5 years gets diligenced thoroughly and can affect multiple by 0.5-1x EBITDA.
Hospital System vs. PE vs. Strategic — Who Pays What
Hospital systems buy urgent care for outpatient referral funnels into their specialty practices and inpatient base. They typically pay 6-9x EBITDA but offer cleanest exits — full cash, no earnout, no roll-over equity required.
PE platforms pay top of range (10-13x) but typically require seller roll-over (10-25% rolled equity) and earnouts tied to EBITDA performance over 2-3 years. Best path if you want to participate in further upside.
Strategic urgent-care chains (FastMed-style) buy at 8-11x but offer the operational integration that creates the most EBITDA lift post-close — your clinic earnings can grow under their playbook, which matters for earnout-based deals.